In ovarian cancer, it has been found that the copy number of the deubiquitinating enzyme USP35 is higher in cancer tissues than in normal ovarian or blood samples and that cancer cells directly deubiquitinate and inactivate STING by upregulating USP35 (70). The gene discussed is USP35; the disease is ovarian carcinoma.